Your browser doesn't support javascript.
loading
Kidney Retransplantation Outcomes: A Paired Recipient Control Study.
Pardinhas, Clara; Leal, Rita; Figueiredo, Carolina; Fernandes, Mariana; Rodrigues, Luís; Guedes, Maria; Santos, Lídia; Romãozinho, Catarina; Escada, Luís; Martinho, António; Sá, Helena Oliveira; Alves, Rui; Figueiredo, Arnaldo.
Affiliation
  • Pardinhas C; Nephrology Department, Coimbra University Hospital Center, Coimbra, Portugal. Electronic address: clarapardinhas@gmail.com.
  • Leal R; Nephrology Department, Coimbra University Hospital Center, Coimbra, Portugal; Nephrology Clinic, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Figueiredo C; Nephrology Department, Coimbra University Hospital Center, Coimbra, Portugal.
  • Fernandes M; University of Aveiro, Aveiro, Portugal.
  • Rodrigues L; Nephrology Department, Coimbra University Hospital Center, Coimbra, Portugal; Nephrology Clinic, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Guedes M; Nephrology Department, Coimbra University Hospital Center, Coimbra, Portugal; Nephrology Clinic, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Santos L; Nephrology Department, Coimbra University Hospital Center, Coimbra, Portugal; Nephrology Clinic, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Romãozinho C; Nephrology Department, Coimbra University Hospital Center, Coimbra, Portugal; Nephrology Clinic, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Escada L; Nephrology Department, Coimbra University Hospital Center, Coimbra, Portugal; Nephrology Clinic, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Martinho A; Centro de Histocompatibilidade do Centro, Instituto Português do Sangue e Transplantação, Coimbra, Portugal.
  • Sá HO; Nephrology Department, Coimbra University Hospital Center, Coimbra, Portugal; Nephrology Clinic, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Alves R; Nephrology Department, Coimbra University Hospital Center, Coimbra, Portugal; Nephrology Clinic, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Figueiredo A; Urology Department, Coimbra University Hospital Center, Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Transplant Proc ; 54(5): 1236-1241, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35643831
ABSTRACT

BACKGROUND:

Despite progressive improvements in graft and patient survival after kidney transplantation over the last decades, an increasing number of patients are waitlisted for retransplantation. Identifying the risk factors for second graft failure can help us improve management for such patients. The aim of this study was to compare the outcomes of kidney retransplantation with those of first transplantation.

METHODS:

This retrospective study included all the recipients of a second kidney transplant between January 2008 and December 2019. For each patient with a second kidney transplant, we selected the paired recipient from the same donor. We excluded recipients of donations from living donors, patient-and-donor pairs with more than 1 transplant, and patients without a pair. The follow-up took place December 31, 2020. We included 152 patients, corresponding to 76 pairs of recipients.

RESULTS:

Patients who underwent a second transplant had significantly higher panel reactive antibody values and longer waiting time for retransplantation. Biopsy-proven acute rejection episodes were doubled in patients undergoing a second transplant (P = .12). There was a lower survival of second grafts at the first, fifth, and 10th year (P < .05). The main factor influencing graft loss for both groups was acute rejection, and, in patients, with a second transplant, acute rejection increased the risk of graft loss by 17 times (odds ratio, 17.5; 95% confidence interval, 4.19-98).

CONCLUSIONS:

The clinical results of second kidney transplants still fall short of first transplants, with the main factor of poor prognosis being acute rejection. In young patients, allocation and immunosuppression management should consider this risk to improve long-term outcomes.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Living Donors / Graft Survival Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transplant Proc Year: 2022 Document type: Article Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Living Donors / Graft Survival Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transplant Proc Year: 2022 Document type: Article Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA